TRPC3/6 Channels Mediate Mechanical Pain Hypersensitivity via Enhancement of Nociceptor Excitability and of Spinal Synaptic Transmission
Zhi‐Chuan Sun,Wen‐Juan Han,Zhi‐Wei Dou,Na Lu,Xu Wang,Fu‐Dong Wang,Sui‐Bin Ma,Zhi‐Cheng Tian,Hang Xian,Wan‐Neng Liu,Ying‐Ying Liu,Wen‐Bin Wu,Wen‐Guang Chu,Huan Guo,Fei Wang,Hui Ding,Yuan‐Ying Liu,Hui‐Ren Tao,Marc Freichel,Lutz Birnbaumer,Zhen‐Zhen Li,Rou‐Gang Xie,Sheng‐Xi Wu,Ceng Luo
DOI: https://doi.org/10.1002/advs.202404342
IF: 15.1
2024-09-30
Advanced Science
Abstract:Sun et al. described how TRPC3/6 in primary sensory neurons get recruited via released bradykinin after peripheral inflammation, which in turn facilitates BDNF secretion from spinal nociceptor terminals and potentiates synaptic transmission and eventually contributes to mechanical pain hypersensitivity. Patients with tissue inflammation or injury often experience aberrant mechanical pain hypersensitivity, one of leading symptoms in clinic. Despite this, the molecular mechanisms underlying mechanical distortion are poorly understood. Canonical transient receptor potential (TRPC) channels confer sensitivity to mechanical stimulation. TRPC3 and TRPC6 proteins, coassembling as heterotetrameric channels, are highly expressed in sensory neurons. However, how these channels mediate mechanical pain hypersensitivity has remained elusive. It is shown that in mice and human, TRPC3 and TRPC6 are upregulated in DRG and spinal dorsal horn under pathological states. Double knockout of TRPC3/6 blunts mechanical pain hypersensitivity, largely by decreasing nociceptor hyperexcitability and spinal synaptic potentiation via presynaptic mechanism. In corroboration with this, nociceptor‐specific ablation of TRPC3/6 produces comparable pain relief. Mechanistic analysis reveals that upon peripheral inflammation, TRPC3/6 in primary sensory neurons get recruited via released bradykinin acting on B1/B2 receptors, facilitating BDNF secretion from spinal nociceptor terminals, which in turn potentiates synaptic transmission through TRPC3/6 and eventually results in mechanical pain hypersensitivity. Antagonizing TRPC3/6 in DRG relieves mechanical pain hypersensitivity in mice and nociceptor hyperexcitability in human. Thus, TRPC3/6 in nociceptors is crucially involved in pain plasticity and constitutes a promising therapeutic target against mechanical pain hypersensitivity with minor side effects.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry